...
首页> 外文期刊>Therapeutic advances in respiratory disease. >Methylprednisolone infusion for life-threatening H1N1-virus infection.
【24h】

Methylprednisolone infusion for life-threatening H1N1-virus infection.

机译:甲基泼尼松龙输注可危及生命的H1N1病毒感染。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: During winter 2009 we treated with prolonged corticosteroid infusion eight consecutive patients affected by H1N1-virus infection and severe pneumonia. The most severe patient was a previously healthy 30-year-old man admitted to hospital because of bilateral pneumonia and severe acute respiratory failure. METHOD: H1N1-virus infection was detected by broncho-alveolar lavage performed on day 1. After some days following admission the patient was still in a life-threatening state, not responding to oseltamivir, protective mechanical ventilation and veno-arterial extracorporeal membrane oxygenation (ECMO). RESULTS: The addition of methylprednisolone infusion at a stress dose (1 mg/kg/24 h) as rescue therapy significantly and rapidly improved the clinical condition. Weaning from ECMO and invasive mechanical ventilation was possible within a relatively few days. CONCLUSION: According to the literature reports more than 34% of H1N1-virus severe infections were treated with corticosteroids. This report and our experience may suggest a possible life-saving use of corticosteroids at a stress dose in severely ill patients with an H1N1-virus infection that is not responding to the most advanced treatments.
机译:背景:2009年冬季,我们连续接受了8例H1N1病毒感染和严重肺炎影响的皮质类固醇激素输注治疗。最严重的患者是先前健康的30岁男性,该患者因双侧肺炎和严重的急性呼吸衰竭而入院。方法:在第1天通过支气管肺泡灌洗检测H1N1病毒感染。入院后几天,患者仍处于危及生命的状态,对奥司他韦,保护性机械通气和静脉动脉体外膜氧合反应无反应( ECMO)。结果:以应激剂量(1 mg / kg / 24 h)添加甲基泼尼松龙作为急救疗法,可大大改善临床状况。在相对几天之内就可以断奶ECMO和有创机械通气。结论:根据文献报道,超过34%的H1N1病毒严重感染是使用皮质类固醇治疗的。这份报告和我们的经验可能表明,在对最先进的治疗没有反应的H1N1病毒感染的重症患者中,以一定剂量服用皮质类固醇可能可以挽救生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号